SWOG clinical trial number
SWOG-8789
A Randomized Study of Etoposide + Cisplatin and Etoposide + Carboplatin (CBDCA) in the Managements of Good Risk Patients with Advanced Germ Cell Tumors
Closed
Phase
Published
Abbreviated Title
A Randomized Study of Etoposide + Cisplatin and Etoposide + Carboplatin (CBDCA) in the Managements of Good Risk Patients with Advanced Germ Cell Tumors
Activated
08/15/1988
Closed
12/15/1990
Publication Information Expand/Collapse
1993
A randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good risk germ cell tumors: A multi-institutional study.
1991
A randomized trial of etoposide + carboplatin (EC) vs. etoposide + cisplatin (EP) in patients (PTS) with metastatic germ cell tumors (GCT).